Nordic Life Science 1
TOP STORIES BUSINESS THE WINNER OF THE SWEDENBIO
AWARD Biotage received the 2019 award for its commitment and contributions to the Swedish life science industry. ACH YEAR SWEDENBIO, the national non-profit association for the life science industry in Color amet this Anders Kronborg, CFO, LEO Pharma Sweden, highlights a company that has stood out when it comes to R&D, business development and growth, but also when it comes to contributions to the industry, which they state Biotage has – for over three decades. Biotage develops solutions for separation within organic and analytical chemistry, as well as purification of antibodies and plasmids. The company has grown into an international company, but it has also remained close to its roots in Uppsala, where its headquarters are located. Thanks to a goal orientated development of its own instruments and sequencing methods, the company has generated profit and grown to nearly 500 employees. “It has been a very exciting The company has announced the sale of ten products to Karo Pharma for EUR 90 million. HE DIVESTED PORTFOLIO is non-core to LEO Pharma’s business, and it was part of the portfolio that LEO Pharma acquired from Bayer in July last year. “This divestment is an important step for LEO Pharma towards strategically aligning our portfolio and increasing focus on 10 innovation and dermatology. This wellestablished portfolio will be better served by Karo Pharma and its team,” says Anders Kronborg, CFO, LEO Pharma. The product portfolio includes four anti-hemorrhoid products (Sheriproct, Doloproct, Neriproct and Ultraproct) and six mainly over-the-counter dermatology products (Ultrabas, Ultralip, Ultraphil, Ultrasicc, Neribas and Ultralan). journey with a focus on platform technologies and a clear strategy of establishing ourselves in every essential market. Over the last 14 years we have also created a result with an average annual improvement of our operating profit with 25%,” says Torben Jörgensen, Chairman, Biotage. Jacob Gunterberg, HealthCap, Torben Jörgensen, Chairman, Biotage and Eva Sjökvist Saers, Deputy Chairman, SwedenBIO NORDICLIFESCIENCE.ORG PHOTO SWEDENBIO